Literature DB >> 3807528

[Splenectomy: surgical indications in malignant hematologic diseases].

F Harder, C Honegger, M Dürig.   

Abstract

Indications for splenectomy in malignant hematological diseases are discussed for relief of symptoms (splenomegaly, cytopenias), for staging (M. Hodgkin) or improvement of survival (hairy cell leukemia). The role of splenectomies is also evaluated for Non-Hodgkin lymphomas, chronic lymphatic leukemia, myelofibrosis and for chronic myeloic leukemia.

Entities:  

Mesh：

Year:  1986        PMID： 3807528     DOI： 10.1007/bf01274363

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN： 0023-8236


  14 in total

1.  Value of splenectomy in non-Hodgkin's lymphoma.

Authors:  J E Kehoe; J M Daly; D J Straus; J J DeCosse
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

2.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

3.  Effect of splenectomy before bone-marrow transplantation on survival in chronic granulocytic leukaemia.

Authors:  A Gratwohl; J Goldman; E Gluckman; F Zwaan
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

Review 4.  Staging laparotomy and splenectomy for Hodgkin's disease: current status.

Authors:  T J Kinsella; E Glatstein
Journal:  Cancer Invest       Date:  1983       Impact factor: 2.176

5.  Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

Authors:  G Flandrin; F Sigaux; G Sebahoun; P Bouffette
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

6.  The value of laparotomy and splenectomy in the staging of Hodgkin's disease.

Authors:  E Glatstein; J M Guernsey; S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

7.  Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group study.

Authors:  J P Hester; C C Waddell; C A Coltman; F S Morrison; R L Stephens; S P Balcerzak; L H Baker; T T Chen
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

8.  Splenectomy for hairy cell leukemia. A clinical review of 63 patients.

Authors:  A S Van Norman; D M Nagorney; J K Martin; R L Phyliky; D M Ilstrup
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

9.  Splenectomy for myelofibrosis.

Authors:  H Järvinen; E Kivilaakso; E Ikkala; P Vuopio; J Hästbacka
Journal:  Ann Clin Res       Date:  1982-04

10.  Splenectomy in hairy cell leukemia: a retrospective multicenter analysis.

Authors:  J Jansen; J Hermans
Journal:  Cancer       Date:  1981-04-15       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.